VAPO
Undervalued by 75.9% based on the discounted cash flow analysis.
Market cap | $13.55 Million |
---|---|
Enterprise Value | $129.05 Million |
Dividend Yield | $0 (2.1376085504342%) |
Earnings per Share | $-9.64 |
Beta | -1.1 |
Outstanding Shares | 6,442,763 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 11.33 |
---|---|
PEG | -323.98 |
Price to Sales | 0.2 |
Price to Book Ratio | -0.17 |
Enterprise Value to Revenue | 1.82 |
Enterprise Value to EBIT | -4.12 |
Enterprise Value to Net Income | -3 |
Total Debt to Enterprise | 0.92 |
Debt to Equity | -1.46 |
No data
No data
Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chro...